NATURE REVIEWS DRUG DISCOVERY

Nature Reviews Drug Discovery (ISSN 1474-1776) is a prestigious monthly journal published by Springer Nature in the United Kingdom, widely recognized as a leading authority in the field of drug discovery. As a high-impact publication indexed in the Science Citation Index (SCI) and consistently ranked in the first quartile of the Chinese Academy of Sciences journal rankings for medicine and pharmacy, the journal serves as a critical resource for researchers, clinicians, and industry professionals. It specializes in publishing comprehensive, high-quality review articles that synthesize current knowledge across the entire drug development lifecycle, from target identification and preclinical research to clinical trials, regulatory policies, and market trends. With a broad scope encompassing oncology, neuroscience, infectious diseases, and metabolic disorders, the journal offers authoritative insights that shape strategic decisions in pharmaceutical research. Although it operates on a subscription-based model rather than open access, which may limit immediate accessibility for some readers, its rigorous peer-review process and high competition for publication ensure that the content meets the highest standards of scientific excellence and impact.